These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23290154)

  • 21. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma.
    Murray CS; Custovic A; Lowe LA; Aldington S; Williams M; Beasley R; Woodcock A
    Allergy Asthma Proc; 2010; 31(5):415-21. PubMed ID: 20929609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study.
    Vogelmeier CF; Bateman ED; Pallante J; Alagappan VK; D'Andrea P; Chen H; Banerji D
    Lancet Respir Med; 2013 Mar; 1(1):51-60. PubMed ID: 24321804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler.
    Masoli M; Weatherall M; Ayling J; Williams M; Beasley R
    Respir Med; 2005 May; 99(5):545-52. PubMed ID: 15823450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of tiotropium and salmeterol/fluticasone propionate on airway wall thickness in chronic obstructive pulmonary disease.
    Hoshino M; Ohtawa J
    Respiration; 2013; 86(4):280-7. PubMed ID: 23880883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of salmeterol and fluticasone propionate combination versus fluticasone propionate on airway function and eosinophilic inflammation in mild asthma.
    Hoshino M; Handa H; Miyazawa T
    Allergol Int; 2009 Sep; 58(3):357-63. PubMed ID: 19454840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma.
    Houghton CM; Lawson N; Borrill ZL; Wixon CL; Yoxall S; Langley SJ; Woodcock A; Singh D
    Respir Res; 2007 Jul; 8(1):52. PubMed ID: 17629923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Asthma control with the salmeterol-fluticasone-combination disc compared to standard treatment].
    Molitor S; Liefring E; Trautmann M
    Pneumologie; 2005 Mar; 59(3):167-73. PubMed ID: 15756629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmeterol/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children.
    de Blic J; Ogorodova L; Klink R; Sidorenko I; Valiulis A; Hofman J; Bennedbaek O; Anderton S; Attali V; Desfougeres JL; Poterre M
    Pediatr Allergy Immunol; 2009 Dec; 20(8):763-71. PubMed ID: 19239660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada.
    Ismaila AS; Risebrough N; Li C; Corriveau D; Hawkins N; FitzGerald JM; Su Z
    Respir Med; 2014 Sep; 108(9):1292-302. PubMed ID: 25175480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salmeterol/fluticasone propionate in a Single Inhaler Device versus theophylline+fluticasone propionate in patients with COPD.
    Cazzola M; Noschese P; Centanni S; Santus P; Di Marco F; Spicuzza L; Di Maria GU
    Pulm Pharmacol Ther; 2004; 17(3):141-5. PubMed ID: 15123223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intervention Studies of Inhaled Corticosteroids Combined with Long-acting Theophylline or Long-acting β
    Wang Y; Chen P; Dai A; Shang S; Kong L
    Clin Ther; 2016 Dec; 38(12):2622-2627.e1. PubMed ID: 27913032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone.
    Katial RK; Bernstein D; Prazma CM; Lincourt WR; Stempel DA
    Allergy Asthma Proc; 2011; 32(2):127-36. PubMed ID: 21189151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients.
    Currie GP; Bates CE; Lee DK; Jackson CM; Lipworth BJ
    Eur J Clin Pharmacol; 2003 May; 59(1):11-5. PubMed ID: 12743669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the efficacy of salmeterol/fluticasone propionate combination in Japanese and Caucasian asthmatics.
    Kawai M; Kempsford R; Pullerits T; Takaori S; Hashimoto K; Takemoto Y; Lötvall J
    Respir Med; 2007 Dec; 101(12):2488-94. PubMed ID: 17900887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluticasone/Salmeterol combination confers benefits in people with asthma who smoke.
    Clearie KL; McKinlay L; Williamson PA; Lipworth BJ
    Chest; 2012 Feb; 141(2):330-338. PubMed ID: 21636667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.